During the past decade, Jose Luis Calleja conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jose Luis Calleja" #1 collaborator was "Hospital Universitario Marqués de Valdecilla" with 1 trials as a collaborator, "Hospital Universitario Ramon y Cajal" with 1 trials as a collaborator and "Hospitales Universitarios Virgen del Rocío" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Jose Luis Calleja" are "Non-Alcoholic Fatty Liver Disease" (1 trials), "Obesity" (1 trials) and "Sarcopenia" (1 trials). Many other conditions were trialed in "Jose Luis Calleja" in a lesser frequency.

Most popular intervention types in "Jose Luis Calleja" are "Behavioral" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Branched chain amino acids (BRCA)" (1 trials), "Endoscopic Gastric Tubulization with OverStitch® system (Apollo Endosurgery, Austin, TX, USA)" (1 trials) and "Lifestyle modification" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jose Luis Calleja" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jose Luis Calleja". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Jose Luis Calleja, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jose Luis Calleja, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".